Multidisciplinary management of lung cancer
A Spira, DS Ettinger - New England Journal of Medicine, 2004 - Mass Medical Soc
A Spira, DS Ettinger
New England Journal of Medicine, 2004•Mass Medical SocDespite years of research, the five-year survival rate among patients with lung cancer is a
mere 14 percent. Lung cancer is divided into two major types—non–small-cell lung cancer
and the more aggressive small-cell lung cancer. This review considers the treatment of each
type in the framework of multidisciplinary management and recent clinical trials.
mere 14 percent. Lung cancer is divided into two major types—non–small-cell lung cancer
and the more aggressive small-cell lung cancer. This review considers the treatment of each
type in the framework of multidisciplinary management and recent clinical trials.
Despite years of research, the five-year survival rate among patients with lung cancer is a mere 14 percent. Lung cancer is divided into two major types — non–small-cell lung cancer and the more aggressive small-cell lung cancer. This review considers the treatment of each type in the framework of multidisciplinary management and recent clinical trials.
The New England Journal Of Medicine